{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:30:39Z","timestamp":1787956239568,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.leukres.2021.106542","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:55:24Z","timestamp":1613868924000},"page":"106542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Association of insurance disparities and survival in adults with multiple myeloma: A non-concurrent cohort study"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-4722","authenticated-orcid":false,"given":"Sarah S.","family":"Makhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Shively","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grettel","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pura","family":"Rodriguez de la Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0660-3091","authenticated-orcid":false,"given":"No\u00ebl C.","family":"Barengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2021.106542_bib0005","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA. Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.leukres.2021.106542_bib0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"issue":"7","key":"10.1016\/j.leukres.2021.106542_bib0015","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1016\/j.clml.2019.03.008","article-title":"Multiple myeloma: clinical updates from the American Society of Hematology Annual Meeting 2018","volume":"19","author":"Terpos","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk"},{"issue":"20","key":"10.1016\/j.leukres.2021.106542_bib0020","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/cncr.30183","article-title":"Impact of marital status, insurance status, income, and race\/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States","volume":"122","author":"Costa","year":"2016","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2021.106542_bib0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1470-2045(08)70032-9","article-title":"Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis","volume":"9","author":"Halpern","year":"2008","journal-title":"Lancet Oncol."},{"issue":"20","key":"10.1016\/j.leukres.2021.106542_bib0030","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","article-title":"Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis","volume":"3","author":"Ailawadhi","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.leukres.2021.106542_bib0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamaoncol.2019.5672","article-title":"Association of insurance status and racial disparities with the detection of early-stage breast cancer","volume":"6","author":"Ko","year":"2020","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2021.106542_bib0040","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3109\/10428194.2015.1011156","article-title":"Socioeconomic status is independently associated with overall survival in patients with multiple myeloma","volume":"56","author":"Fiala","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.leukres.2021.106542_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome","volume":"335","author":"Attal","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.leukres.2021.106542_bib0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbmt.2014.12.024","article-title":"Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma","volume":"21","author":"Costa","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"10.1016\/j.leukres.2021.106542_bib0055","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bbmt.2015.03.005","article-title":"Re: disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma","volume":"21","author":"Fiala","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"12","key":"10.1016\/j.leukres.2021.106542_bib0060","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/PAS.0000000000000749","article-title":"The Surveillance, Epidemiology, and End Results (SEER) program and pathology: toward strengthening the critical relationship","volume":"40","author":"Duggan","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"17","key":"10.1016\/j.leukres.2021.106542_bib0065","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1002\/cncr.27380","article-title":"Survival disparities by Medicaid status: an analysis of 8 cancers","volume":"118","author":"Koroukian","year":"2012","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.leukres.2021.106542_bib0070","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/cam4.1246","article-title":"Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis","volume":"6","author":"Ailawadhi","year":"2017","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.leukres.2021.106542_bib0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/NCC.0b013e3182693522","article-title":"Personal financial effects of multiple myeloma and its treatment","volume":"36","author":"Goodwin","year":"2013","journal-title":"Cancer Nurs."},{"issue":"8","key":"10.1016\/j.leukres.2021.106542_bib0080","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.23753","article-title":"Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents","volume":"89","author":"Al-Hamadani","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2021.106542_bib0085","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbmt.2016.03.008","article-title":"Time to insurance approval in private and public payers does not influence survival in patients who undergo hematopoietic cell transplantation","volume":"22","author":"Bhatt","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.leukres.2021.106542_bib0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/DCR.0000000000001068","article-title":"Disparities in colon cancer survival by insurance type: a population-based analysis","volume":"61","author":"Pulte","year":"2018","journal-title":"Dis. Colon Rectum"},{"issue":"5","key":"10.1016\/j.leukres.2021.106542_bib0095","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/cam4.1331","article-title":"The influence of insurance type on stage at presentation, treatment, and survival between Asian American and non-Hispanic White lung cancer patients","volume":"7","author":"Tantraworasin","year":"2018","journal-title":"Cancer Med"},{"issue":"31","key":"10.1016\/j.leukres.2021.106542_bib0100","doi-asserted-by":"crossref","first-page":"51663","DOI":"10.18632\/oncotarget.18381","article-title":"Impact of insurance status on the survival of gallbladder cancer patients","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.leukres.2021.106542_bib0105","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/lary.26713","article-title":"Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery","volume":"127","author":"Rohlfing","year":"2017","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.leukres.2021.106542_bib0110","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamaoto.2017.0837","article-title":"Association of insurance and community-level socioeconomic Status with treatment and outcome of squamous cell carcinoma of the pharynx","volume":"143","author":"Shin","year":"2017","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"10","key":"10.1016\/j.leukres.2021.106542_bib0115","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ijd.14026","article-title":"Socioeconomic status and survival for patients with melanoma in the United States: an NCDB analysis","volume":"57","author":"Sitenga","year":"2018","journal-title":"Int. J. Dermatol."},{"issue":"9","key":"10.1016\/j.leukres.2021.106542_bib0120","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1055-9965.EPI-12-0466","article-title":"Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States","volume":"21","author":"Flowers","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"11","key":"10.1016\/j.leukres.2021.106542_bib0125","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2018-03-839035","article-title":"Disparities in survival by insurance status in follicular lymphoma","volume":"132","author":"Goldstein","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2021.106542_bib0130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.24774","article-title":"The impact of health insurance status on the survival of patients with head and neck cancer","volume":"116","author":"Kwok","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2021.106542_bib0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoncol.2017.3846","article-title":"Trends in cancer survival by health insurance status in California from 1997 to 2014","volume":"4","author":"Ellis","year":"2018","journal-title":"JAMA Oncol."},{"issue":"12","key":"10.1016\/j.leukres.2021.106542_bib0140","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/1097-0142(19841215)54:12<3085::AID-CNCR2820541246>3.0.CO;2-Z","article-title":"Race, poverty, and survival in multiple myeloma","volume":"54","author":"Savage","year":"1984","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.leukres.2021.106542_bib0145","first-page":"931","article-title":"Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States)","volume":"17","author":"Gebregziabher","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.leukres.2021.106542_bib0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1022268103136","article-title":"Myeloma and race: a review of the literature","volume":"22","author":"Benjamin","year":"2003","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.leukres.2021.106542_bib0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.2012.09124.x","article-title":"Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups","volume":"158","author":"Ailawadhi","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"24","key":"10.1016\/j.leukres.2021.106542_bib0160","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.2019000406","article-title":"With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study","volume":"133","author":"Fillmore","year":"2019","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.leukres.2021.106542_bib0165","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2012-07-443606","article-title":"Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach","volume":"121","author":"Baker","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2021.106542_bib0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-020-0284-7","article-title":"Dissecting racial disparities in multiple myeloma","volume":"10","author":"Marinac","year":"2020","journal-title":"Blood Cancer Journal"},{"issue":"5","key":"10.1016\/j.leukres.2021.106542_bib0175","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/TA.0b013e31826fc844","article-title":"Undiagnosed medical comorbidities in the uninsured: a significant predictor of mortality following trauma","volume":"73","author":"Duron","year":"2012","journal-title":"J Trauma Acute Care Surg"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:21Z","timestamp":1758934881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":35,"alternative-id":["S0145212621000436"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106542","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of insurance disparities and survival in adults with multiple myeloma: A non-concurrent cohort study","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106542"}}